case 3: risk assessment and elderly patients with cll
Published 4 years ago • 63 plays • Length 4:47Download video MP4
Download video MP3
Similar videos
-
8:56
case 3: elderly patient with treatment-naïve cll
-
8:19
case 3: an elderly patient with cll, mutated tp53 and notch, unmutated ighv
-
6:26
managing elderly patients with cll
-
5:47
case 3: response to frontline therapy and toxicity management
-
3:58
case 3: managing ibrutinib-associated toxicities in cll
-
1:47
age impacts treatment options for patients with cll
-
3:17
case 1: assessing risk in cll
-
40:51
dr ami desai, neuroblastoma basics
-
5:55
case 1: an elderly patient with newly diagnosed high-risk cll
-
4:10
case 3: intolerance to btk inhibitors in cll
-
7:03
case 3: progression on ibrutinib followed by richter transformation
-
5:00
cll: patient evaluation and risk stratification
-
4:49
risk stratification for a patient with cll
-
4:27
stratifying patients with cll by stage and risk status
-
5:03
case 3: therapeutic approaches for richter transformation
-
6:15
case 3: geriatric assessment in myeloma
-
27:28
risk assessment in cll treatment
-
2:03
case 4: a patient with relapsed/refractory cll
-
5:00
upfront ibrutinib in cll